Search

name of propantheline bromide

Input interpretation

propantheline bromide
propantheline bromide

Chemical names and formulas

formula | C_23H_30NO_3Br Hill formula | C_23H_30BrNO_3 name | propantheline bromide IUPAC name | methyl-dipropan-2-yl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium bromide alternate names | ercotina | neometantyl | neopepulsan | prodixamon mass fractions | Br (bromine) 17.8% | C (carbon) 61.6% | H (hydrogen) 6.74% | N (nitrogen) 3.12% | O (oxygen) 10.7%
formula | C_23H_30NO_3Br Hill formula | C_23H_30BrNO_3 name | propantheline bromide IUPAC name | methyl-dipropan-2-yl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium bromide alternate names | ercotina | neometantyl | neopepulsan | prodixamon mass fractions | Br (bromine) 17.8% | C (carbon) 61.6% | H (hydrogen) 6.74% | N (nitrogen) 3.12% | O (oxygen) 10.7%

Structure diagram

Structure diagram
Structure diagram
vertex count | 28 edge count | 29 Schultz index | 7779 Wiener index | 1850 Hosoya index | 341376 Balaban index | 1.643
vertex count | 28 edge count | 29 Schultz index | 7779 Wiener index | 1850 Hosoya index | 341376 Balaban index | 1.643

Basic properties

molar mass | 448.4 g/mol phase | solid (at STP) melting point | 158 °C
molar mass | 448.4 g/mol phase | solid (at STP) melting point | 158 °C

Units

Hydrophobicity and permeability properties

predicted LogP hydrophobicity | 2.67 predicted LogS | -6.75
predicted LogP hydrophobicity | 2.67 predicted LogS | -6.75

Basic drug properties

approval status | approved | small molecule drug categories | anti-ulcer agent | antimuscarinic | antispasmodic | muscarinic antagonist dosage forms | oral: tablet
approval status | approved | small molecule drug categories | anti-ulcer agent | antimuscarinic | antispasmodic | muscarinic antagonist dosage forms | oral: tablet
brand names | pro-banthine | propanthel
brand names | pro-banthine | propanthel

Chemical identifiers

CAS number | 50-34-0 Beilstein number | 3643037 PubChem CID number | 9279 PubChem SID number | 9709 SMILES identifier | CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-] InChI identifier | InChI=1/C23H30NO3.BrH/c1-16(2)24(5, 17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13, 16-17, 22H, 14-15H2, 1-5H3;1H/q+1;/p-1/fC23H30NO3.Br/h;1h/qm;-1 InChI key | VVWYOYDLCMFIEM-UHFFFAOYAG EU number | 200-030-6 RTECS number | BP8249200
CAS number | 50-34-0 Beilstein number | 3643037 PubChem CID number | 9279 PubChem SID number | 9709 SMILES identifier | CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-] InChI identifier | InChI=1/C23H30NO3.BrH/c1-16(2)24(5, 17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13, 16-17, 22H, 14-15H2, 1-5H3;1H/q+1;/p-1/fC23H30NO3.Br/h;1h/qm;-1 InChI key | VVWYOYDLCMFIEM-UHFFFAOYAG EU number | 200-030-6 RTECS number | BP8249200

Toxicity properties

RTECS classes | drug | mutagen
RTECS classes | drug | mutagen